Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI

Journal of Nuclear Medicine

Volumn 48, Issue 2, 2007, Pages 288-294

  Higuchi, Takahiro ^a   Nekolla, Stephan G ^a   Jankaukas, Antanas ^a   Weber, Axel W ^a   Huisman, Marc C ^a   Reder, Sybille ^a   Ziegler, Sibylle I ^a   Schwaiger, Markus ^a   Bengel, Frank M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

MRI; Myocardial infarction; Rat; Small animal PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; DIAGNOSTIC AGENT; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROCARDIOGRAM; GLUCOSE METABOLISM; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HISTOPATHOLOGY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; WISTAR RAT; ANIMAL; ELECTROCARDIOGRAPHY; HEART; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; METABOLISM; PATHOLOGY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ELECTROCARDIOGRAPHY; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEART; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 34047238231     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Imam SK. Molecular nuclear imaging: the radiopharmaceuticals. Cancer Biother Radiopharm. 2005;20:163-172.
2. Quarantelli M, Berkouk K, Prinster A, et al. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med. 2004;45:192-201.
3. Schillaci O, Simonetti G. Fusion imaging in nuclear medicine: applications of dual-modality systems in oncology. Cancer Biother Radiopharm. 2004;19:1-10.
4. Boone JM, Velazquez O, Cherry SR. Small-animal x-ray dose from micro-CT. Mol Imaging. 2004;3:149-158.
5. Constantine G, Shan K, Flamm SD, Sivananthan MU. Role of MRI in clinical cardiology. Lancet. 2004;363:2162-2171.
6. Pereira RS, Prato FS, Wisenberg G, Sykes J, Yvorchuk KJ. The use of Gd-DTPA as a marker of myocardial viability in reperfused acute myocardial infarction. Int J Cardiovasc Imaging. 2001;17:395-404.
7. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med. 1996;36:684-693.
8. Mulder WJ, Strijkers GJ, van Tilborg GA, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed. 2006;19:142-164.
9. Pichler BJ, Judenhofer MS, Catana C, et al. Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. J Nucl Med. 2006;47:639-647.
10. Higuchi T, Taki J, Nakajima K, Kinuya S, Namura M, Tonami N. Time course of discordant BMIPP and thallium uptake after ischemia and reperfusion in a rat model. J Nucl Med. 2005;46:172-175.
11. Ott I, Keller U, Knoedler M, et al. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J. 2005;19:992-994.
12. 99mTc-labeled annexin V. J Nucl Med. 2004;45:1536-1541.
13. Gibbons RJ, Valeti US, Araoz PA, Jaffe AS. The quantification of infarct size. J Am Coll Cardiol. 2004;44:1533-1542.
14. Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction: Stent Versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study investigators. N Engl J Med. 2000;343:385-391.
15. Surti S, Karp JS, Perkins AE, Freifelder R. Design evaluation of A-PET: a high sensitivity animal PET camera. IEEE Trans Nucl Sci. 2003;50:1357-1363.
16. Surti S, Karp JS, Perkins AE, et al. Imaging performance of A-PET: a small animal PET camera. IEEE Trans Med Imaging. 2005;24:844-852.
17. Ibrahim T, Nekolla SG, Hornke M, et al. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol. 2005;45:544-552.
18. Chiang S, Cardi C, Matej S, et al. Clinical validation of fully 3-D versus 2.5-D RAMLA reconstruction on the Philips-ADAC CPET PET scanner. Nucl Med Commun. 2004;25:1103-1107.
19. Nekolla SG, Miethaner C, Nguyen N, Ziegler SI, Schwaiger M. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med. 1998;25:1313-1321.
20. Flacke S, Allen JS, Chia JM, et al. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model. Radiology. 2003;226:731-738.
21. Degabriele NM, Griesenbach U, Sato K, et al. Critical appraisal of the mouse model of myocardial infarction. Exp Physiol. 2004;89:497-505.
22. Kudo T, Fukuchi K, Annala AJ, et al. Noninvasive measurement of myocardial activity concentrations and perfusion defect sizes in rats with a new small-animal positron emission tomograph. Circulation. 2002;106:118-123.
23. Cheung JY, Conover C, Regen DM, Whitfield CF, Morgan HE. Effect of insulin on kinetics of sugar transport in heart muscle. Am J Physiol. 1978;234:E70-E78.
24. Schoder H, Campisi R, Ohtake T, et al. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. J Am Coll Cardiol. 1999;33:1328-1337.
25. Fahey FH, Gage HD, Buchheimer N, et al. Evaluation of the quantitative capability of a high-resolution positron emission tomography scanner for small animal imaging. J Comput Assist Tomogr. 2004;28:842-848.
26. Bartlett ML, Bacharach SL, Voipio-Pulkki LM, Dilsizian V. Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects. J Nucl Med. 1995;36:188-195.
27. Links JM, Becker LC, Anstett F. Clinical significance of apical thinning after attenuation correction. J Nucl Cardiol. 2004;11:26-31.
28. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation. 2001;104:2838-2842.
29. 99mTc-DTPA autoradiography in rats. Radiology. 1999;211:698-708.
30. Bencherif B, Stumpf MJ, Links JM, Frost JJ. Application of MRI-based partial-volume correction to the analysis of PET images of mu-opioid receptors using statistical parametric mapping. J Nucl Med. 2004;45:402-408.
31. Marsden PK, Strul D, Keevil SF, Williams SC, Cash D. Simultaneous PET and NMR. Br J Radiol. 2002;75(suppl):S53-S59.
32. Pichler BJ, Judenhofer MS, Catana C, et al. Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. J Nucl Med. 2006;47:639-647.